What is Cervical Cancer Screening?
Cervical cancer screening is a vital preventive health process used to identify pre-cancerous cell changes or high-risk viral infections before cervical cancer has a chance to develop. This proactive approach allows medical providers to detect anomalies in the cervix — the lower part of the uterus that connects to the vagina — at a highly treatable stage. By scheduling regular screenings, women can significantly reduce their risk of developing cervical cancer.
At Miami Women’s Center, our cervical cancer screening program uses sensitive diagnostic laboratory testing, careful tracking protocols, and patient-centered care to protect your long-term reproductive health, closely coordinated with our Pap smear and HPV testing services.
Request an AppointmentOur Screening Methods & Care Pathways
When you establish your preventive care with Miami Women’s Center, we determine the optimal screening method based on your age, lifestyle, and individual medical history:
- Liquid-based cytology (Pap smear): Collecting cells from the outer surface and canal of the cervix to evaluate them for squamous cell abnormalities or glandular changes.
- High-risk HPV testing: Analyzing the sample at a molecular level to detect the presence of HPV strains 16, 18, and other high-risk variations known to cause cellular changes.
- Abnormal result follow-up: If your screening indicates atypical or dysplastic cells, our clinic provides access to diagnostic colposcopies, biopsies, and management protocols to treat precancerous tissue. See our advanced colposcopy page for more detail.
Frequently Asked Questions About Cervical Cancer Screening
Cervical Cancer Screening at Miami Women’s Center
Is cervical cancer screening different from a routine pelvic exam?
Yes. A routine pelvic exam is a physical evaluation where your gynecologist manually checks your reproductive organs for lumps, pain, or structural irregularities. Cervical cancer screening requires collecting a microscopic sample of cells or fluid directly from the cervix using a soft brush or spatula to test for cellular mutations or viral DNA in a laboratory setting.
How often should I undergo cervical cancer screening?
We follow the clinical guidelines established by leading national health organizations:
- Ages 21 to 29: Screening is recommended every 3 years using a conventional or liquid-based Pap smear.
- Ages 30 to 65: Screening shifts to a high-risk HPV test alone every 5 years, a co-test every 5 years, or a standard Pap smear alone every 3 years.
- Ages 65 and older: Screenings can typically be discontinued with a consistent history of normal results over the prior 10 years and no history of high-grade precancerous lesions.
Can I still be screened if I am currently on my period?
While mild spotting or very light bleeding will not interfere with modern liquid-based laboratory tests, it’s generally ideal to schedule outside active menstruation, as heavy flow can occasionally obscure the sample.
What are the main risk factors for developing cervical cancer?
The primary risk factor is persistent infection with high-risk strains of HPV. Other factors that can increase risk include a compromised immune system, smoking, long-term use of oral contraceptives, or missing routine screening appointments.
Is cervical cancer screening painful?
Most patients describe brief pressure or mild discomfort rather than pain. The sample collection itself typically takes only a few seconds.
Can HPV clear on its own without treatment?
Many HPV infections clear naturally within one to two years as the immune system fights the virus. Regular screening helps track whether an infection is persisting or if it’s leading to cell changes that need attention.
What follow-up is needed after an abnormal screening result?
Follow-up depends on the specific finding, and may range from a repeat test in a year to a colposcopy for closer evaluation. Your provider will explain your specific recommendation clearly.